Mostly due to AI-related fears of disruption, ServiceNow is currently trading at some of the lowest valuation multiples in its history. Learn more about NOW stock here.

Over almost three months from late October to January, ServiceNow (NOW)’s stock fell 37%, despite modest revenue growth. Concerns regarding AI disruption, a cautious outlook for FY26, and an ...

Subscription revenues of $3,466 million in Q4 2025, representing 21% year-over-year growth, 19.5% in constant currency Total revenues of $3,568 million in Q4 2025, representing 20.5% year-over-year ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20260128041272/en/ The articles, information, and content displayed on this webpage ...

The MarketWatch News Department was not involved in the creation of this content. -- ServiceNow exceeds guidance across all Q4 2025 topline growth and profitability metrics -- Subscription revenues of ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today announced financial results for its fourth quarter ended December 31, 2025, with ...

SANTA CLARA, Calif., January 28, 2026--ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today announced financial results for its fourth quarter ended December 31, 2025, with ...

January payrolls show 4.4% unemployment; Amazon cuts offset healthcare hiring; investors rotate into AI storage stocks. Check out why trends now favor tech.

Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Somer G. Anderson is CPA, doctor of ...

Indicator species are living organisms that tell us that something has changed or is going to change in their environment. They can be easily observed, and studying them is considered a cost-effective ...

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention.